Inventor · disambiguated record
Peter Brams
Also filed as: BRAMS PETER · BRAMS PETER S
60 granted patents·20 pending applications·2,106 citations·filing 1991–2024
99Inventor score
Top patents by PatentIndex Score
80 records- 0198US7910798B2Transgenic animals expressing chimeric antibodies for use in preparing human antibodiesMEDAREX INC·Filed 2007·Granted Mar 22, 2011·130 cites·5 claims
- 0297US7960515B2Binding molecules to the human OX40 receptorBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 14, 2011·205 cites·12 claims
- 0397US6113898AHuman B7.1-specific primatized antibodies and transfectomas expressing said antibodiesIDEC PHARMA CORP·Filed 1995·Granted Sep 5, 2000·207 cites·11 claims
- 0497US5811524ANeutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofIDEC PHARMA CORP·Filed 1995·Granted Sep 22, 1998·205 cites·11 claims
- 0596US8236930B2Binding molecules to the human OX40 receptorMIN JING·Filed 2011·Granted Aug 7, 2012·85 cites·5 claims
- 0696US7217796B2Neutralizing human anti-IGFR antibodySCHERING CORP·Filed 2003·Granted May 15, 2007·105 cites·81 claims
- 0796US5958765ANeutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofIDEC PHARMA CORP·Filed 1996·Granted Sep 28, 1999·185 cites·28 claims
- 0895US9028824B2Binding molecules to the human OX40 receptorMIN JING·Filed 2012·Granted May 12, 2015·75 cites·22 claims
- 0995US8232449B2Transgenic animals expressing chimeric antibodies for use in preparing human antibodiesTANAMACHI DAWN M·Filed 2011·Granted Jul 31, 2012·33 cites·8 claims
- 1095US7192585B2CD80 specific antibodiesBIOGEN IDEC INC·Filed 2005·Granted Mar 20, 2007·17 cites·20 claims
- 1194US8383118B2Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1MEDAREX INC·Filed 2006·Granted Feb 26, 2013·24 cites·11 claims
- 1294US5866125ANeutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofIDEC PHARMA CORP·Filed 1996·Granted Feb 2, 1999·86 cites·5 claims
- 1393US9683998B2Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereofPFIZER·Filed 2014·Granted Jun 20, 2017·32 cites·13 claims
- 1493US9631025B2Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodiesSQUIBB & SONS LLC·Filed 2015·Granted Apr 25, 2017·11 cites·12 claims
- 1593US6537809B2Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofXENEREX BIOSCIENCES·Filed 2000·Granted Mar 25, 2003·74 cites·29 claims
- 1693US6413771B1Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofIDEC PHARMA CORP·Filed 1999·Granted Jul 2, 2002·60 cites·7 claims
- 1793US5939068ANeutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofIDEC PHARMA CORP·Filed 1996·Granted Aug 17, 1999·83 cites·7 claims
- 1893US5840298ANeutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofIDEC PHARMA CORP·Filed 1996·Granted Nov 24, 1998·75 cites·11 claims
- 1992US6893638B2Methods for treating b cell lymphoma using CD80-specific antibodiesFiled 2001·Granted May 17, 2005·40 cites·5 claims
- 2091US9138475B2Human monoclonal antibodies to Fucosyl-GM1 and methods for using anti-Fucosyl-GM1 antibodiesSQUIBB & SONS LLC·Filed 2013·Granted Sep 22, 2015·12 cites·16 claims
- 2191US7947807B2Method for obtaining G protein-coupled receptor (GPCR) diffraction-quality crystals employing a monoclonal antibody that binds to the third intracellular loop (IL3)UNIV LELAND STANFORD JUNIOR·Filed 2008·Granted May 24, 2011·18 cites·8 claims
- 2291US7491393B2Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2007·Granted Feb 17, 2009·4 cites·20 claims
- 2391US7175847B1Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80 binding to CTLA-4BIOGEN IDEC INC·Filed 2000·Granted Feb 13, 2007·13 cites·45 claims
- 2491US5955364ANeutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofIDEC PHARMA CORP·Filed 1996·Granted Sep 21, 1999·63 cites·9 claims
- 2590US11474112B2Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereofPFIZER·Filed 2019·Granted Oct 18, 2022·4 cites·27 claims
- 2690US8450464B2Human monoclonal antibodies that bind CXCR4KUHNE MICHELLE·Filed 2007·Granted May 28, 2013·24 cites·42 claims
- 2790US7153508B2Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4BIOGEN IDEC INC·Filed 2002·Granted Dec 26, 2006·19 cites·26 claims
- 2888US7510712B2Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2007·Granted Mar 31, 2009·5 cites·20 claims
- 2987US7851181B2Neutralizing human anti-IGFR antibodySCHERING CORP·Filed 2007·Granted Dec 14, 2010·7 cites·45 claims
- 3087US7847068B2Neutralizing human anti-IGFR antibodySCHERING CORP·Filed 2006·Granted Dec 7, 2010·7 cites·99 claims
- 3187US7425447B2Host cells expressing 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2006·Granted Sep 16, 2008·5 cites·44 claims
- 3286US7667021B2Neutralizing human anti-IGFR antibodySCHERING CORP·Filed 2006·Granted Feb 23, 2010·6 cites·46 claims
- 3386US7417128B27C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2006·Granted Aug 26, 2008·5 cites·13 claims
- 3482US8039596B2Alpha 5-beta 1 antibodies and their usesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Oct 18, 2011·4 cites·10 claims
- 3582US2022403046A1Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 antibodiesSQUIBB & SONS LLC·Filed 2022·Application pending·0 cites
- 3681US7510713B2Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2007·Granted Mar 31, 2009·1 cites·20 claims
- 3780US7414123B2Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2006·Granted Aug 19, 2008·1 cites·16 claims
- 3879US12372536B2Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereofPFIZER·Filed 2022·Granted Jul 29, 2025·0 cites·30 claims
- 3979US8188235B2Antibodies to IL-6 and their usesRAJPAL ARVIND·Filed 2009·Granted May 29, 2012·3 cites·10 claims
- 4078US10196452B2Binding molecules to the human OX40 receptorPFIZER·Filed 2017·Granted Feb 5, 2019·1 cites·16 claims
- 4178US7501264B2Methods of producing 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2007·Granted Mar 10, 2009·1 cites·23 claims
- 4277US8173779B2Neutralizing human anti-IGFR antibodyWANG YAN·Filed 2010·Granted May 8, 2012·2 cites·16 claims
- 4376US6709654B1Treatment of psoriasis using anti-B7.1 (CD80) antibodiesFiled 1999·Granted Mar 23, 2004·28 cites·7 claims
- 4476US2022002428A1Binding molecules to the human ox40 receptorPFIZER·Filed 2021·Application pending·0 cites
- 4573US9220244B2Transgenic animals expressing chimeric antibodies for use in preparing human antibodiesTANAMACHI DAWN M·Filed 2012·Granted Dec 29, 2015·1 cites·8 claims
- 4673US7323170B2Anti-CD80 antibodiesBIOGEN IDEC INC·Filed 2004·Granted Jan 29, 2008·4 cites·30 claims
- 4771US7118924B2Method for producing human antibodies in SCID mice which uses dendritic cells pulsed with antigen-antibody complexes and antigen-antibody complexes as immunizing agentsBIOGEN IDEC INC·Filed 2001·Granted Oct 10, 2006·2 cites·17 claims
- 4871US2009124791A1Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigensBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 4968US2019315881A1Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 antibodiesSQUIBB & SONS LLC·Filed 2019·Application pending·0 cites
- 5068US2008282363A1Methods for producing human antibodies in scid miceCOCCIA MARCO ANTHONY·Filed 2008·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Brams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →